Biopol Chemicals Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Revenue	946.78	811.43	492.21	174.33
Revenue Growth	-	64.85%	182.35%	-
Cost of Revenue	723.75	631.26	403.03	146.42
Gross Profit	223.03	180.17	89.18	27.91
Selling, General & Admin	24.39	23.33	14.34	3.5
Other Operating Expenses	25.65	21.59	10.01	5.62
Operating Expenses	53.08	45.91	25.27	9.52
Operating Income	169.95	134.27	63.92	18.38
Interest Expense	-14.76	-12.35	-4.52	-0.81
Interest & Investment Income	1.05	1.05	-	-
Currency Exchange Gain (Loss)	0.47	0.47	-0.07	-0.02
Other Non Operating Income (Expenses)	-2.85	-2.85	-1.53	-0.43
Pretax Income	153.86	120.58	57.8	17.12
Income Tax Expense	40.4	30.84	14.68	4.31
Net Income	113.46	89.74	43.12	12.81
Net Income to Common	113.46	89.74	43.12	12.81
Net Income Growth	-	108.11%	236.69%	-
Shares Outstanding (Basic)	10	8	8	-
Shares Outstanding (Diluted)	10	8	8	-
Shares Change	23.09%	4.72%	-	-
EPS (Basic)	11.65	10.83	5.45	-
EPS (Diluted)	11.65	10.83	5.45	-
EPS Growth	-	98.72%	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024
Period Ending	Sep '26 Sep 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Free Cash Flow	-303.45	-269.66	-24.38	-89.43
Free Cash Flow Per Share	-31.17	-32.54	-3.08	-
Gross Margin	23.56%	22.20%	18.12%	16.01%
Operating Margin	17.95%	16.55%	12.99%	10.54%
Profit Margin	11.98%	11.06%	8.76%	7.35%
Free Cash Flow Margin	-32.05%	-33.23%	-4.95%	-51.30%
EBITDA	172.99	135.25	64.84	18.78
EBITDA Margin	18.27%	16.67%	13.17%	10.77%
D&A For EBITDA	3.05	0.98	0.92	0.4
EBIT	169.95	134.27	63.92	18.38
EBIT Margin	17.95%	16.55%	12.99%	10.54%
Effective Tax Rate	26.26%	25.58%	25.40%	25.19%
Revenue as Reported	949.06	813.72	492.21	174.33